Runben Biotechnology Co., Ltd. (SHA:603193)
26.13
-0.03 (-0.11%)
Apr 29, 2026, 3:00 PM CST
-26.33% (1Y)
| Market Cap | 10.57B |
| Revenue (ttm) | 1.57B |
| Net Income (ttm) | 322.94M |
| Shares Out | 404.59M |
| EPS (ttm) | 0.80 |
| PE Ratio | 32.69 |
| Forward PE | 28.10 |
| Dividend | 0.46 (1.76%) |
| Ex-Dividend Date | n/a |
| Volume | 5,099,883 |
| Average Volume | 7,406,818 |
| Open | 25.98 |
| Previous Close | 26.16 |
| Day's Range | 25.50 - 26.46 |
| 52-Week Range | 20.28 - 44.00 |
| Beta | 0.18 |
| RSI | 62.36 |
| Earnings Date | Apr 23, 2026 |